Shanghai Kehua Bio-engineering Co Ltd - Company Profile

Powered by

All the sales intelligence you need on Shanghai Kehua Bio-engineering Co Ltd in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Shanghai Kehua Bio-engineering Co Ltd fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Shanghai Kehua Bio-engineering Co Ltd.

Back to companies

Shanghai Kehua Bio-engineering Co Ltd: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Shanghai Kehua Bio-engineering Co Ltd (KHB) develops, manufactures and markets in vitro diagnostic (IVD) devices and related products. The company's major products include diagnostic reagents and instruments for biochemical diagnosis, immunodiagnostics, molecular diagnosis, and point-of-care testing. Its products are utilized in clinical diagnosis and treatment, blood screening, public health, food safety, and scientific research. Kehua Bio has established strategic partnerships with leading international companies to enhance research and development innovation. KHB has research and development (R&D) and manufacturing sites in Italy, Shenzhen, Xi'an and Suzhou. The company has sales support facilities in major cities in China and markets products in China and other countries through distributors. KHB is headquartered in Shanghai, China.

Gain a 360-degree view of Shanghai Kehua Bio-engineering Co Ltd and make more informed decisions for your business Gain a 360-degree view of Shanghai Kehua Bio-engineering Co Ltd and make more informed decisions for your business Learn more
Headquarters China

Address No.1189, Qinzhou North Road, Xuhui District, Shanghai, 200233


Telephone 86 21 64950625

No of Employees 2,033

Industry Medical Equipment

Ticker Symbol & Exchange 002022 (SHE)

Revenue (2024) $244.8M -27.5% (2024 vs 2023)

EPS XYZ

Net Income (2024) XYZ -173.7% (2024 vs 2023)

Market Cap* $346.5M

Net Profit Margin (2024) XYZ -277.7% (2024 vs 2023)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Shanghai Kehua Bio-engineering Co Ltd premium industry data and analytics

1

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

Products and Services

Products
Immunologic Diagnosis:
Enzyme-Linked Immunosorbent Assay (Elisa) Kit
ELISA reader, plate washer
XYZ
XYZ
XYZ
Understand Shanghai Kehua Bio-engineering Co Ltd portfolio and identify potential areas for collaboration Understand Shanghai Kehua Bio-engineering Co Ltd portfolio and identify potential areas for collaboration Learn more
Image for loader

Competitor Comparison

Key Parameters Shanghai Kehua Bio-engineering Co Ltd Thermo Fisher Scientific Inc Shenzhen Mindray Bio-Medical Electronics Co Ltd Edan Instruments Inc Beijing Strong Biotechnologies Inc
Headquarters China United States of America China China China
City Shanghai Waltham Shenzhen Shenzhen Beijing
State/Province Shanghai Massachusetts Guangdong Guangdong Beijing
No. of Employees 2,033 125,000 21,667 2,546 1,098
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Li Ming President; Chairman Executive Board 2024 50
Zang Xianfeng Chief Financial Officer Senior Management - 51
Fang Luo Chief Financial Officer Senior Management - 52
Ma Zhichao Vice Chairman Executive Board - 46
Jin Hongying Secretary; Director; Vice President Executive Board - 54
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Shanghai Kehua Bio-engineering Co Ltd key executives to enhance your sales strategy Gain insight into Shanghai Kehua Bio-engineering Co Ltd key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?